US Stock MarketDetailed Quotes

XLO Xilio Therapeutics

Watchlist
  • 1.150
  • -0.130-10.16%
Close Apr 19 16:00 ET
  • 1.181
  • +0.031+2.65%
Post 19:57 ET
39.64MMarket Cap-413P/E (TTM)

About Xilio Therapeutics Company

Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.

Company Profile

SymbolXLO
Company NameXilio Therapeutics
Listing DateOct 22, 2021
Issue Price16.00
Founded2015
CEODr. Rene Russo, Pharm.D.
MarketNASDAQ
Employees73
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address828 Winter Street,Suite 300
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-857-524-2466
Websitehttp://www.xiliotx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Rene Russo, Pharm.D.
  • Director, Chief Executive Officer and President
  • 2.21M
  • Christopher Frankenfield
  • Chief Operating Officer
  • --
  • Dr. Scott Coleman
  • Chief Development Officer
  • --
  • Dr. Katarina Luptakova
  • Chief Medical Officer
  • --
  • Kevin M. Brennan
  • Senior Vice President, Finance and Accounting, Principal Financial Officer and Principal Accounting Officer
  • --
  • Paul J. Clancy
  • Chairman of the Board
  • 88.69K
  • Robert Ross
  • Director
  • 66.39K
  • Dr. Yuan Xu, PhD
  • Director
  • 59.57K
  • Tomas J. Heyman
  • Director
  • 76.74K
  • Sara Bonstein
  • Independent Director
  • 68.29K
  • Christina Rossi
  • Independent Director
  • 64.44K
  • Daniel Curran
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg